Clinical pharmacokinetics of antipsychotics in pediatric populations: a sco** review focusing on dosing regimen

J Liang, LT Ringeling, RA Hermans… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction Achieving optimal clinical responses and minimizing side effects through
precision dosing of antipsychotics in children and adolescents with psychiatric disorders …

[HTML][HTML] Umbrella review: association between antipsychotic drugs and metabolic syndrome hallmarks in children and adolescents

C Carnovale, V Battini, C Santoro, MP Riccio… - Journal of the American …, 2024 - Elsevier
Objective To summarize the available evidence on metabolic parameters indicating
metabolic adverse effects and risk of metabolic syndrome in children and adolescents …

What role for long-acting injectable antipsychotics in managing schizophrenia spectrum disorders in children and adolescents? A systematic review

I Baeza, A Fortea, D Ilzarbe, G Sugranyes - Pediatric Drugs, 2023 - Springer
Background Long-acting injectable antipsychotics (LAIAs) are an efficacious and well-
tolerated treatment in adults with schizophrenia spectrum disorders (SSD). However, there is …

The atypical antipsychotic risperidone targets hypothalamic melanocortin 4 receptors to cause weight gain

L Li, ES Yoo, X Li, SC Wyler, X Chen, R Wan… - Journal of Experimental …, 2021 - rupress.org
Atypical antipsychotics such as risperidone cause drug-induced metabolic syndrome.
However, the underlying mechanisms remain largely unknown. Here, we report a new …

Common practical questions–and answers–at the British Association for Psychopharmacology child and adolescent psychopharmacology course

S Cortese, FMC Besag, B Clark… - Journal of …, 2023 - journals.sagepub.com
The British Association for Psychopharmacology course on child and adolescent
psychopharmacology has been run for more than 20 years and is currently a very popular …

First do no harm: use off-label antipsychotic medication in children and adolescents with great caution

PJ Hoekstra, A Dietrich - European Child & Adolescent Psychiatry, 2022 - Springer
In children and adolescents, antipsychotic medication is regularly prescribed on an off-label
base, mostly for disruptive behavior or irritability. Especially in children, these medications …

Psychotropic Medications for Sleep Disorders in Autism Spectrum Disorders

DA Rossignol, RE Frye - … of Autism and Pervasive Developmental Disorder …, 2022 - Springer
Sleep-related abnormalities are common in individuals with autism spectrum disorders
(ASD) and correlate with ASD severity and ASD-related symptoms. To identify the evidence …

Comparative physiological effects of antipsychotic drugs in children and young people: a network meta-analysis

M Rogdaki, RA McCutcheon, E D'Ambrosio… - The Lancet Child & …, 2024 - thelancet.com
Background The degree of physiological responses to individual antipsychotic drugs is
unclear in children and adolescents. With network meta-analysis, we aimed to investigate …

The Utah psychotropic oversight program: collaboratively addressing antipsychotic use within youth in foster care without prior authorization

ET Monson, S Shastri, D Chen, SL Madden… - Frontiers in …, 2023 - frontiersin.org
Objectives Fostered youth have increased risk of exposure to trauma. Antipsychotic
medications are often utilized within the foster care system, potentially to address …

[PDF][PDF] Psychopharmacology and personality disorder: Treatment or enhancement

S Jerotic, M Kostic - … . Cambridge University Press. https://doi. org …, 2024 - researchgate.net
An in-depth examination into the application of psychopharmacology in the treatment of
personality disorders highlights the multifaceted debates about using medication for …